ciprofloxacin has been researched along with Urinary Bladder, Overactive in 2 studies
Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.
Urinary Bladder, Overactive: Symptom of overactive detrusor muscle of the URINARY BLADDER that contracts with abnormally high frequency and urgency. Overactive bladder is characterized by the frequent feeling of needing to urinate during the day, during the night, or both. URINARY INCONTINENCE may or may not be present.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Women with overactive bladder and urodynamic diagnosis of detrusor overactivity who were refractory to anticholinergics, and had histological evidence of urothelial inflammation were treated with a 6-week course of rotating antibiotics." | 1.39 | Changes in nerve growth factor level and symptom severity following antibiotic treatment for refractory overactive bladder. ( Cartwright, R; Derpapas, A; Fernando, R; Gallo, P; Khullar, V; Vijaya, G, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Khan, MH | 1 |
| Baldo, O | 1 |
| Koenig, P | 1 |
| Shaikh, N | 1 |
| Vijaya, G | 1 |
| Cartwright, R | 1 |
| Derpapas, A | 1 |
| Gallo, P | 1 |
| Fernando, R | 1 |
| Khullar, V | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Use of Prophylactic Antibiotics Prior to OnabotulinumtoxinA Treatment of Overactive Bladder: a Randomized Controlled Trial[NCT05519072] | Phase 4 | 140 participants (Anticipated) | Interventional | 2022-08-16 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 other studies available for ciprofloxacin and Urinary Bladder, Overactive
| Article | Year |
|---|---|
Use of prophylactic antibiotics for intra-vesicle Botox® injection.
Topics: Acetylcholine Release Inhibitors; Administration, Intravesical; Anti-Bacterial Agents; Antibiotic Pr | 2017 |
Changes in nerve growth factor level and symptom severity following antibiotic treatment for refractory overactive bladder.
Topics: Adult; Anti-Bacterial Agents; Biomarkers; Cephalexin; Ciprofloxacin; Cohort Studies; Doxycycline; Fe | 2013 |